Study drug RMC-9805 for patients with KRAS G12D solid tumors (RMC-9805-001)

Clinical Trial Grant

Duke Scholars

Principal Investigator John Strickler Medicine, Medical Oncology

Awarded By

Revolution Medicines, Inc

Start Date

March 19, 2024

End Date

March 10, 2029

Awarded By

Revolution Medicines, Inc

Start Date

March 19, 2024

End Date

March 10, 2029